RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease

Acta Neuropathologica

Volumn 112, Issue 4, 2006, Pages 405-415

  Donahue, John E ^a   Flaherty, Stephanie L ^a   Johanson, Conrad E ^a   Duncan III, John A ^a   Silverberg, Gerald D ^b   Miller, Miles C ^a   Tavares, Rosemarie ^a   Yang, Wentian ^c   Wu, Qian ^a   Sabo, Edmond ^a   Hovanesian, Virginia ^a   Stopa, Edward G ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Blood brain barrier; Low density lipoprotein receptor related protein 1; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; ELDERLY CARE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; SENILE PLAQUE; STAINING; SYSTEMIC CIRCULATION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; BRAIN; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; LDL-RECEPTOR RELATED PROTEIN 1; MALE; NEURONS;

EID: 33749157416     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-006-0115-3     Document Type: Article

References (32)

1. (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease The National Institute on Aging, and Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging 18:S1-2
2. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259
3. Cras P, Kawai M, Siedlak S, Mulvihill P, Gambetti P, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1990) Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol 137:241-246
4. Cummings BJ, Su JH, Geddes JW, Van Nostrand WE, Wagner SL, Cunningham DD, Cotman CW (1992) Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease. Neuroscience 48:763-777
5. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134
6. Deane R, Du YS, Submamaryan R, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt A, Armstrong D, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9:907-913
7. Grimsley PG, Quinn KA, Chesterman CN, Owensby DA (1999) Evolutionary conservation of circulating soluble low density lipoprotein receptor-related protein-like ("LRP-like") molecules. Thromb Res 94:153-164
8. Harris-White ME, Frautschy SA (2005) Low density lipoprotein receptor-related proteins (LRPs), Alzheimer's and cognition. Curr Drug Targets CNS Neurol Disord 4:469-480
9. Herz J, Marschang P (2003) Coaxing the LDL receptor family into the fold. Cell 112:289-292
10. Mackic J, Stins M, McComb J, Calero M, Ghiso J, Kim K, Yan S, Stern D, Schmidt A, Frangione B, Zlokovic B (1998) Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40 asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102:734-743
11. Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV (2002) Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging 23:405-412
12. Pluta R, Barcikowska M, Januszewski S, Misicka A, Lipkowski A (1996) Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide. Neuroreport 7:1261-1265
13. Poduslo J, Curran G, Sanyal B, Selkoe D (1999) Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier. Neurobiol Dis 6:190-199
14. Powers J, Skeen J (1988) Ultrastructural heterogeneity in cerebral amyloid of Alzheimer's disease. Acta Neuropathol (Berl) 76:613-623
15. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580
16. Rubenstein E (1998) Relationship of senescence of cerebrospinal fluid circulatory system to dementias of the aged. Lancet 351:283-285
17. Sasaki N, Toki S, Chowei H, Saito T, Nakano N, Hayashi Y, Takeuchi M, Makita Z (2001) Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Res 888:256-262
18. Selkoe DJ (1989) Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging 10:387-395
19. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924:17-25
20. Shibata M, Yamada S, Kumar S, Calero M, Bading J, Frangione B, Holtzman D, Miller C, Strickland D, Ghiso J, Zlokovic B (2000) Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499
21. Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD, Bronte-Stewart H, Rubenstein E, Possin K, Saul TA (2001) The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer's type. Neurology 57:1763-1766
22. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol 2:506-511
23. Siman R, Card JP, Nelson RB, Davis LG (1989) Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron 3:275-285
24. Stewart PA, Hayakawa K, Akers MA, Vinters HV (1992) A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 67:734-742
25. Tooyama I, Kawamata T, Akiyama H, Kimura H, Moestrup SK, Gliemann J, Matsuo A, McGeer PL (1995) Subcellular localization of the low density lipoprotein receptor-related protein (alpha 2-macroglobulin receptor) in human brain. Brain Res 691:235-238
26. Wolf BB, Lopes MB, VandenBerg SR, Gonias SL (1992) Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low-density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42
27. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691
28. Yan SD, Stern D, Kane MD, Kuo YM, Lampert HC, Roher AE (1998) RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. Restor Neurol Neurosci 12:167-173
29. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, Kindy M (2000) Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med 6:643-651
30. Zerbinatti CV, Bu G (2005) LRP and Alzheimer's disease. Rev Neurosci 16:123-135
31. Zlokovic B (1997) Can blood-brain barrier play a role in the development of cerebral amyloidosis and Alzheimer's disease pathology. Neurobiol Dis 4: 23-26
32. Zlokovic BV (2004) Clearing amyloid through the blood-brain barrier. J Neurochem 89:807-811